Article
EGFR Mutation Subtypes Modulate Distinct Metabolic Profiles and Clinical Outcomes in Lung Cancer: A Retrospective Analysis
2025-06-27
Abstract excerpt
<h4>ABSTRACT</h4> Lung cancer continues to be a leading contributor of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) as most prevalent cases. Identification of epidermal growth factor receptor (EGFR) mutations has profoundly enhanced our understanding and treatment of NSCLC, leading to the development of precision therapies, including EGFR tyrosine kinase inhibitors (TKIs). This retr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a32a1441-8bfd-5830-b369-b90b1464adac
- DOI
- 10.1101/2025.06.26.659534
